These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25277616)

  • 1. Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the Malmö Diet and Cancer study.
    Hallengren E; Almgren P; Engström G; Hedblad B; Persson M; Suhr J; Bergmann A; Melander O
    J Am Coll Cardiol; 2014 Oct; 64(14):1452-60. PubMed ID: 25277616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Terminal Prosomatostatin as a Risk Marker for Cardiovascular Disease and Diabetes in a General Population.
    Hedbäck T; Almgren P; Nilsson PM; Melander O
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3437-44. PubMed ID: 27399347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.
    Melander O; Maisel AS; Almgren P; Manjer J; Belting M; Hedblad B; Engström G; Kilger U; Nilsson P; Bergmann A; Orho-Melander M
    JAMA; 2012 Oct; 308(14):1469-75. PubMed ID: 23047361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment.
    Hallengren E; Almgren P; Rosvall M; Östling G; Persson M; Bergmann A; Struck J; Engström G; Hedblad B; Melander O
    BMC Cardiovasc Disord; 2017 May; 17(1):125. PubMed ID: 28511669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
    Zhu K; Knuiman M; Divitini M; Murray K; Lim EM; St John A; Walsh JP; Hung J
    Heart; 2018 Jun; 104(11):895-903. PubMed ID: 29066610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney Disease.
    Sandesara PB; O'Neal WT; Tahhan AS; Hayek SS; Lee SK; Khambhati J; Topel ML; Hammadah M; Alkhoder A; Ko YA; Gafeer MM; Beshiri A; Murtagh G; Kim JH; Wilson P; Shaw L; Epstein SE; Sperling LS; Quyyumi AA
    Am J Cardiol; 2018 Jun; 121(12):1461-1466. PubMed ID: 29628129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between high-sensitivity C-reactive protein and both cardiovascular, total mortality events in middle-aged Chinese adults].
    Dong Y; Wang ZW; Wang X; Tian Y; Zhang LF; Chen Z; Cao HQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Apr; 39(4):428-432. PubMed ID: 29699031
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of Low Frequency Protein Truncating Stop-Codon Variants and Fasting Concentration of Growth Hormone.
    Hallengren E; Almgren P; Engström G; Persson M; Melander O
    PLoS One; 2015; 10(6):e0128348. PubMed ID: 26086970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality.
    Selvin E; Rawlings A; Lutsey P; Maruthur N; Pankow JS; Steffes M; Coresh J
    Diabetes; 2016 Jan; 65(1):201-8. PubMed ID: 26395741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
    Smith JG; Newton-Cheh C; Almgren P; Struck J; Morgenthaler NG; Bergmann A; Platonov PG; Hedblad B; Engström G; Wang TJ; Melander O
    J Am Coll Cardiol; 2010 Nov; 56(21):1712-9. PubMed ID: 21070922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study.
    Lutsey PL; Alonso A; Selvin E; Pankow JS; Michos ED; Agarwal SK; Loehr LR; Eckfeldt JH; Coresh J
    J Am Heart Assoc; 2014 Jun; 3(3):e000936. PubMed ID: 24922628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants of growth hormone and GH-related phenotypes.
    Hallengren E; Almgren P; Svensson M; Gallo W; Engström G; Persson M; Melander O
    BMC Genomics; 2017 Oct; 18(1):822. PubMed ID: 29065852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome.
    Batra G; Ahlsson A; Lindahl B; Lindhagen L; Wickbom A; Oldgren J
    Ups J Med Sci; 2019 Jan; 124(1):70-77. PubMed ID: 30265179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of high sensitivity cardiac troponin T in patients with congenital heart disease.
    Abiko M; Inai K; Shimada E; Asagai S; Nakanishi T
    J Cardiol; 2018 Apr; 71(4):389-393. PubMed ID: 29108668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Eisen A; Bhatt DL; Steg PG; Eagle KA; Goto S; Guo J; Smith SC; Ohman EM; Scirica BM;
    J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27680665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.